A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

NCT06701526 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Eptinezumab

Sponsor

H. Lundbeck A/S